Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy

The recent success of therapies directly targeting the angiogenic mediator, vascular endothelial growth factor (VEGF), for the treatment of proliferative diabetic retinopathy has encouraged clinicians to extend the use of anti-VEGF therapies for the treatment of another ischemic retinal vascular dis...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Main Authors: Jee, Kathleen, Rodrigues, Murilo, Kashiwabuchi, Fabiana, Applewhite, Brooks P., Han, Ian, Lutty, Gerard, Goldberg, Morton F., Semenza, Gregg L., Montaner, Silvia, Sodhi, Akrit
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2017
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5568377/
https://ncbi.nlm.nih.gov/pubmed/28832635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0183320
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares